The AKT/β-catenin signaling pathway is notably connected to MDR development in various solid tumors, such as gastric cancer 24, 25, liver cancer 26, colon cancer 27, 28, breast cancer 29, and lung cancer. The gene discussed is AKT1; the disease is lung carcinoma.